Revance(RVNC) - 2024 Q3 - Quarterly Results

Exhibit 99.1 REVANCE Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update – On August 11, 2024, Revance and Crown Laboratories, Inc. entered into a merger agreement. As a result of discussions between the Revance and Teoxane, Crown and Revance agreed to extend the deadline upon which the tender offer must commence to November 12, 2024. The tender offer has not yet commenced. – Revance entered into an amendment to the Exclusive Distribution Agreement with Teoxane for the distributi ...